Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > INSIGHTFUL! MEANINGFUL! NON-VEXATIOU
View:
Post by ISAloser247 on Nov 16, 2011 4:46pm

INSIGHTFUL! MEANINGFUL! NON-VEXATIOU

..Post#28525431 8/25/2010 Dilution,smilution, if you are in at 15 cents, heck even if you are in at under 50 cents you are going to do extraordinarily well here. Granted if you were in at $3.00 the prospects are more doubtful (although far from hopeless)and certainly longer term and I guess if I was one of the original longs I would be more than a little justified in griping about about the naivete/inexperience of Foster and his advisors in the past(I mean Roche made them look like hillbillies) but I only care about where we are going from here. I could give a f#ck if Foster makes a fortune in the process(show me a founder of a successful biotech that hasn't)so long as I make mine. macbethorfaustquite right, ol'chap, luv u bro.....
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities